Lifetime Price for Xfinity Extreme Triple Play Class Action Lifetime Price for Xfinity Extreme Triple Play
Arm & Hammer Litter Pans Ad Alert Arm & Hammer Litter Pans When it comes to supporting ad claims, there’s no substitute for product testing.
Fitzgerald Auto Mall Ad Alert Fitzgerald Auto Mall Consumer accuses dealership of pulling a bait and switch.
Seven Figure Publishing Ad Alert Seven Figure Publishing TINA.org breaks down company’s claim that you can collect “extra” money from the Social Security Administration.
TINA.org’s Year in Review 2018 Blog TINA.org’s Year in Review 2018 It was another successful year outing deceptive marketing on multiple fronts.
Androzene Ad Alert Androzene The science behind this male enhancement supplement is far from rockhard.
SoFi Ad Alert SoFi FTC alleges lender made false statements about the student loan refinancing savings of its customers.
Nutrio2 Ad Alert Nutrio2 The breathing room for this supplement decreases as NAD refers claims to the FTC.
T-Mobile’s ‘Best Unlimited Network’ Claims Ad Alert T-Mobile’s ‘Best Unlimited Network’ Claims Being the best means more than just being the fastest.
Ad or Not? Kim Kardashian and Flat Tummy Lollipops Consumer News Ad or Not? Kim Kardashian and Flat Tummy Lollipops Kim takes two steps forward and one step back in remedying her latest influencer marketing controversy.
TINA.org to Team National: Take Down Questionable Income Claims Consumer News TINA.org to Team National: Take Down Questionable Income Claims TINA.org’s #TNTruth social media campaign exposes company’s inappropriate income claims.
Airplus Shoe Insoles Ad Alert Airplus Shoe Insoles NAD and maker of Airplus shoe insoles get off on the wrong foot over health-related claims.
Recovery24 Ad Alert Recovery24 Another detox supplement is forced to answer for its misleading advertising.
Bay Area Houses 4 Cash Ad Alert Bay Area Houses 4 Cash Postcard marked “property notification” leads to additional red flags.
BounceBack by Mannatech Ad Alert BounceBack by Mannatech MLM’s health claims face another regulatory challenge.